Geode Capital Management LLC Grows Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Geode Capital Management LLC lifted its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 1.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 515,979 shares of the company’s stock after acquiring an additional 8,510 shares during the quarter. Geode Capital Management LLC owned 1.27% of Phibro Animal Health worth $10,838,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. boosted its position in Phibro Animal Health by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock worth $31,809,000 after purchasing an additional 20,604 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Phibro Animal Health by 18.0% during the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock worth $13,348,000 after buying an additional 96,787 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in shares of Phibro Animal Health by 35.6% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 322,090 shares of the company’s stock valued at $6,764,000 after buying an additional 84,599 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in Phibro Animal Health by 8.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 290,656 shares of the company’s stock valued at $6,104,000 after acquiring an additional 22,263 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in Phibro Animal Health by 2.9% in the 4th quarter. Bank of New York Mellon Corp now owns 272,632 shares of the company’s stock worth $5,725,000 after acquiring an additional 7,747 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Price Performance

Phibro Animal Health stock opened at $17.04 on Wednesday. The company has a fifty day simple moving average of $21.14 and a 200-day simple moving average of $22.23. The firm has a market capitalization of $690.17 million, a price-to-earnings ratio of 35.50, a PEG ratio of 0.45 and a beta of 0.63. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health Co. has a 52-week low of $12.30 and a 52-week high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were given a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.82%. Phibro Animal Health’s payout ratio is 100.00%.

Analyst Ratings Changes

PAHC has been the topic of several recent analyst reports. Morgan Stanley set a $20.00 price objective on shares of Phibro Animal Health in a report on Tuesday, April 15th. Barclays raised their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Finally, StockNews.com lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $19.75.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.